Nouvelles thérapies ciblées pour le traitement de maladies de la peau avec des anomalies génétiques

Tuberous Sclerosis Topical Rapamycin could be used to treat facial angiofibromas (“Adenoma Sebaceum”) (link) (Archives of Dermatology, 2010) Neurofibromatosis (Recklinghausen’s Disease) Mast cells play an important role The c-Kit receptor on mast cells is stimulated by mediators that are liberated by Schwann cells The activation of mast cells then induces the liberation of maediators that…

Nouvelles thérapies ciblées pour le traitement de maladies de la peau avec des anomalies génétiques

Tuberous Sclerosis Topical Rapamycin could be used to treat facial angiofibromas (“Adenoma Sebaceum”) (link) (Archives of Dermatology, 2010) Neurofibromatosis (Recklinghausen’s Disease) Mast cells play an important role The c-Kit receptor on mast cells is stimulated by mediators that are liberated by Schwann cells The activation of mast cells then induces the liberation of maediators that…